Managing Director, Apollon SE
Constantin Schön is Managing Director at Apollon SE, the investment holding company of the Schoen family with €2b in assets under management. Constantan sits on the boards of directors of Schoen Klinik SE and Silony Medical International AG, and he is CEO of Silony Medical Corp., Silony’s US subsidiary.
Constantin also oversees Apollon SE’s investments in OT4, OTM, OTC, OTN and OTH, which all sell, develop and manufacture specialty orthotics for conservative medical treatments. Prior to joining the family business, Constantin spent two years at QuintilesIMS as a consultant for pharmaceutical companies in Shanghai and London.